Magnesium Ascorbyl Phosphate

Delivers stable vitamin C activity for antioxidant protection against UV-induced and environmental free radical damage. Inhibits melanin formation by suppressing tyrosinase activity, gradually reducing the appearance of dark spots and hyperpigmentation. Supports collagen biosynthesis through enzymatic release of ascorbic acid, which serves as a cofactor for collagen-stabilizing hydroxylases. Provides a unique hydrating benefit not commonly seen with other vitamin C forms, improving skin moisture levels and plumpness. Reduces UV-induced erythema and supports the photoprotective efficacy of sunscreen when used as an antioxidant base layer. Gentle enough for sensitive skin types that cannot tolerate low-pH vitamin C formulations.

Apply MAP-containing serums or creams to clean skin in the morning and evening. In the morning, apply before sunscreen to provide an antioxidant boost. MAP is compatible with a wide range of other active ingredients including niacinamide, hyaluronic acid, peptides, and ceramides due to its neutral pH. Effective concentrations typically range from 3% to 10%. The product should be applied to slightly damp skin to enhance absorption. Allow full absorption before applying subsequent layers. Consistent use for 8 to 16 weeks is recommended before evaluating brightening results, as the indirect conversion mechanism yields more gradual improvements.

Clinical research published in the Journal of the American Academy of Dermatology demonstrated that a 10% magnesium ascorbyl phosphate formulation significantly lightened melasma and solar lentigines in the majority of treated subjects after 12 weeks, with no reported irritation. In vitro studies confirm that MAP is efficiently dephosphorylated by skin phosphatases to release biologically active L-ascorbic acid in the epidermis. Research has shown that MAP possesses a distinctive hydrating property, increasing skin moisture content by approximately 15% compared to untreated controls in a 4-week study, potentially through enhancement of the ceramide-producing pathway. Stability testing reveals that MAP maintains over 85% of its activity after 6 months at 40 degrees Celsius, significantly outperforming pure ascorbic acid under identical conditions. Comparative studies rank MAP as less potent than SAP in antimicrobial activity against Cutibacterium acnes but comparable in tyrosinase inhibition when tested at equivalent molar concentrations.